Judges Scientific Regulatory News (JDG)

24 Jul 2009 08:38

Judges Scientific plc (the "Company")

Directors' Interests and Grant of Options

24 July 2009

The Company announces that, on 23 July 2009, it granted options over an aggregate of 60,000 new Ordinary Shares of 5p each in the capital of the Company ("Ordinary Shares"), comprising options over 44,400 new Ordinary Shares under the Company's Approved Plan and options over 15,600 new Ordinary Shares under the Company's Unapproved Plan. These are all exercisable between three and ten years from the date of grant at an exercise price of 92p per share.

Included in these figures are options over 8,900 shares under the Approved Plan and over a further 1,100 under the Unapproved Plan which were granted to Ralph Cohen, Finance Director of the Company. As a result, he now holds options over 67,000 new Ordinary Shares, comprising 28,900 under the Approved Plan and 38,100 under the Unapproved Plan. Also included are options granted to David Barnbrook, a Director and the Chief Operating Officer of the Company, over 10,000 new Ordinary Shares under the Unapproved Plan. As a result, he now holds options over 50,000 new Ordinary Shares, comprising 28,450 under the Approved Plan and 21,550 under the Unapproved Plan. The new options granted to these two directors will vest on achievement of future earnings per share targets.

Ends

Enquiries:

Judges Scientific plc

David Cicurel, CEO

01342 323 600

Shore Capital

Pascal Keane

020 7408 4090

Cardew Group

Melvyn Marckus

07775 896491